| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.095 | 0.1 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |